Fenticonazole

Quick links to important sections

Fenticonazole

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenticonazole

Property Description
Active Ingredient Fenticonazole (commonly as Fenticonazole Nitrate)
Form Cream, Ointment, Vaginal Capsules (Ovules)
Pharmacological Class Imidazole Antifungal (Azole)
General Purpose Resolving superficial mycotic infections
Origin Synthetic

Fenticonazole: Defining Its Identity and Origin

Fenticonazole is a synthetic medicinal entity, chemically classified as a racemic imidazole derivative, which is the active ingredient often administered as the salt Fenticonazole Nitrate. This compound, prepared in a laboratory, serves as the core component of several treatments, such as Lomexin and Gynoxin, designed for localized anti-infective therapy. The drug is prepared as a single product (monotherapy) for topical treatment of the skin and mucosal surfaces. Its specialized forms, including emollient cream, ointment, and Vaginal Capsules (Ovules), facilitate the direct delivery of the active substance to the site of infection.


Pharmacological Class and Broad-Spectrum Action

Fenticonazole is officially classified as an Imidazole Antifungal agent, placing it within the broader azole family of anti-infective medications. This pharmacological class confirms its primary function is to inhibit the growth and survival of fungal organisms by disrupting the synthesis of ergosterol, an essential component of the microbial membrane. The drug's action is considered broad-spectrum, a feature that extends its efficacy beyond fungi. Pharmacological studies support Fenticonazole's ability to exhibit activity against certain Gram-positive bacteria and the protozoan Trichomonas vaginalis, making it a versatile local anti-infective agent for superficial microbial imbalances.


General Purpose of Fenticonazole

The general purpose of Fenticonazole is to function as a broad-spectrum antimycotic to resolve localized infections caused by susceptible pathogens. By attacking the integrity of the microbial cell structure, the drug serves to stop the progression of mycotic infections and fungal infections. This focused, local action, combined with its dual activity against select bacteria and parasites, allows it to offer comprehensive treatment, helping to address the symptoms associated with complex microbial imbalances by controlling the source of the infection.

What side effects are possible with Fenticonazole?

Possible Side Effects and Safety Information

The safety profile for Fenticonazole is primarily characterized by localized application site reactions due to its poor systemic absorption when used as directed. The most commonly documented adverse reactions are mild and transient, classified within the Skin and Subcutaneous Tissue Disorders system-organ class.

Frequency-Classified Adverse Reactions

Classification Adverse Reaction Notes
Very Rare (<1/10,000) Burning sensation, Pruritus (Itching), Erythema (Redness), Rash Generally reported as transient and rapidly resolving.
Not Known Hypersensitivity Reactions Potential for severe allergic reactions, requiring immediate cessation of treatment.

Key Safety Considerations

  • Serious Adverse Reactions: The risk of hypersensitivity or allergic reactions is the most significant systemic safety concern, and treatment must be stopped if sensitization occurs, especially with prolonged use.

  • Safety Restriction (Barrier Contraceptives): Fenticonazole intravaginal preparations have been officially documented to damage the latex used in condoms and diaphragms, rendering these barrier methods ineffective for contraception. Alternative measures are required during treatment.

  • Use in Specific Populations: The use of Fenticonazole is not recommended during pregnancy or lactation. Regulatory documents indicate that the drug or its metabolites have been shown to cross the placental barrier and are excreted in breast milk in animal studies.

  • Excipient Warnings: Formulations may contain ingredients (e.g., propylene glycol, cetyl alcohol) that can officially cause local skin irritation or contact dermatitis in susceptible individuals.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents regarding Fenticonazole topical and intravaginal formulations emphasize the inherent safety profile tied to its route of administration. Due to the drug's very low systemic absorption, official labeling confirms that no cases of overdose have been reported following the intended local application of the medication. This low risk profile is a critical component of the official regulatory classification.


Documented Manifestations and Emergency Action

The primary overdose concern outlined by health authorities relates specifically to the scenario of accidental oral ingestion of the medication. The official prescribing information states that consuming the product orally, which is not the intended route, may result in specific adverse gastrointestinal symptoms.

Overdose Manifestation Mandated Emergency Action
Accidental ingestion resulting in abdominal pain or vomiting. Seek immediate medical attention or go to the nearest hospital immediately.

Supportive Measures and Antidote

For cases of accidental oral ingestion, the required emergency response is to seek professional medical care immediately. The clinical management is officially classified as symptomatic and supportive. No specific antidote is known for Fenticonazole overdose. The regulatory profile is constrained by the drug’s intended local delivery and low potential for systemic toxicity.

Therapeutic Uses of Fenticonazole

What Fenticonazole treats: main uses and benefits

Fenticonazole is an antifungal compound authorized for the topical management of several superficial fungal infections. Its primary use involves addressing vulvovaginal candidiasis, which is commonly known as a yeast infection, to alleviate the associated local discomfort. The medication may help reduce common symptoms like itching, burning, and irritation in the affected area, supporting the return to daily comfort.

The medication is also utilized in managing other types of skin and mucosal fungal conditions. These include infections caused by Candida species and may extend to certain forms of tinea and pityriasis versicolor. The application of this treatment may assist in limiting the spread of fungal growth, which supports the body's natural processes in clearing visible signs of the infection.


Quick Fact: Management of Fungal Symptoms

Fenticonazole is used to assist with the localized discomfort associated with fungal infections, such as itching and irritation.

Eligibility and Restrictions for Use

Who Can and Cannot Use Fenticonazole?

Eligibility for Fenticonazole use is defined by official regulatory documents, primarily based on the patient's age and existing medical status.

Absolute Contraindications

Fenticonazole is contraindicated in patients with known hypersensitivity (allergy) to the active substance, Fenticonazole, to other imidazole derivatives, or to any of the inactive ingredients (excipients) in the specific formulation.

Eligibility by Population

Population Category Regulatory Status
Established Use Adults and adolescents aged 16 years or above.
Pediatric Restriction Not recommended for children under 16 years; safety and efficacy have not been established in this age group.
Conditional Use (Pregnancy) Restricted; must be used under the supervision of a physician. The vaginal applicator should not be used during pregnancy.
Conditional Use (Lactation) Restricted; must be used under the supervision of a physician.

Required Consultation

Specific populations require consultation with a physician before use, including individuals over 60 years of age, those with a history of recurrent infections (more than two in six months), or a history of a sexually transmitted disease (STD).

What should I know about interactions with other medicines?

Fenticonazole is an imidazole antifungal agent primarily used in topical or vaginal formulations, such as creams, ovules, or capsules. Due to its very low systemic absorption following local application, the risk of clinically significant interactions with medicines taken orally is generally considered minimal. However, patients should always inform their healthcare provider about all prescription drugs, over-the-counter medicines, and herbal supplements they are currently using.

Products That May Interact Locally

The most important considerations for interactions relate to local products and contraceptives:

  • Barrier Contraceptives: The oily excipients and fat-containing bases used in vaginal formulations of fenticonazole (e.g., vaginal capsules or ovules) may damage the latex of condoms and diaphragms. This damage can compromise their structural integrity, rendering these barrier methods ineffective for preventing pregnancy or sexually transmitted infections.
  • Spermicidal Products: Concurrent use of fenticonazole with spermicides is generally not recommended, as local vaginal treatments may inactivate the spermicidal agent, reducing its contraceptive efficacy.

Patients using barrier methods for contraception should use alternative reliable methods (such as hormonal contraceptives) or abstain from sexual intercourse during treatment with fenticonazole and for at least a few days after treatment completion.

Mechanism of Action

Fenticonazole exerts an anti-infective action through a multimodal mechanism that targets the pathogen's structure, metabolism, and virulence simultaneously.

Disruption of Pathogen Cell Integrity

The primary action involves the direct inhibition of Lanosterol 14alpha-demethylase (CYP51), a vital fungal enzyme. Blocking this enzyme prevents the formation of ergosterol, the key sterol required for the fungal cell membrane. This molecular cascade leads to the accumulation of toxic sterols and compromises the membrane's stability and permeability. This instability results in a fungicidal or fungistatic consequence, leading to the arrest of microbial replication and cellular lysis.

Dual-Action Metabolic and Virulence Inhibition

Beyond the structural attack, Fenticonazole interferes with key processes required for pathogen survival. It inhibits fungal cytochrome oxidases, causing an intracellular build-up of toxic peroxide compounds that accelerate cell death. Additionally, it acts as an inhibitor of Secretory Aspartate Proteinase (SAP), a fungal virulence factor. This latter mechanism physiologically limits the pathogen's ability to invade host tissue and is linked to the mitigation of tissue-damaging enzymatic activity.

Broad-Spectrum Metabolic Interference

The drug's mechanism extends to non-fungal pathogens by targeting key metabolic enzymes like pyruvate oxido-reductase in susceptible protozoa and certain bacteria. By inhibiting this enzyme, Fenticonazole deprives these organisms of the necessary energy and building blocks for survival and replication. This mechanism enables a broad-spectrum physiological effect by arresting the growth and division of multiple pathogen classes.

Dosage and Administration Information

How to use Fenticonazole

Fenticonazole administration is strictly confined to two local routes: Intravaginal and External Topical/Cutaneous, depending on the formulation prescribed. Dosage forms include vaginal capsules (ovules), vaginal cream (often 2%), and various external products such as creams, solutions, and powders.

The standardized intravaginal dosing protocol utilizes two core schedules. The first involves a single-dose use of a 600 mg vaginal capsule. The alternative is a short course where a 200 mg vaginal capsule is administered once daily for three successive days. For the vaginal cream, the unit dose is measured as one applicator full (approximately 5 grams).

All intravaginal doses are procedurally required to be inserted deeply and scheduled specifically at bedtime. This timing is designed to promote maximum contact time for the active substance at the application site. Treatment for superficial dermal infections, such as those addressed by the cutaneous creams or powders, typically follows a longer course, often requiring application once or twice daily for a duration ranging from two to four weeks.

The standard adult regimen applies to adolescents 16 years and above. However, the product is not recommended for children under 16 due to a lack of established usage data. Women over the age of 60 are officially advised to seek prior physician consultation before use. If the short-course treatment proves insufficient, the regimen may be repeated after 3 days.

Recent Clinical Evidence

Research Evidence / Overview of studies for Fenticonazole


Evidence for Use in Vulvovaginal Candidiasis (VVC)

Research examining Fenticonazole's role in investigating vaginal yeast infections—conditions characterized by acute or disruptive episodes—has primarily relied on Randomized Controlled Trials (RCTs) and comparative clinical trials. According to study protocols, these studies were designed to explore short-term symptom changes. Researchers monitored two main outcome types: mycological assessment (measuring the status of fungal organisms) and clinical assessment (tracking changes in physician-scored symptoms like itching, burning, and discharge).

Findings describe patterns observed in these studies, which included comparisons to other established antifungal agents. The research highlights changes measured in both the mycological status and the scores related to the patients' physical discomfort. However, the evidence is limited regarding long-term outcomes. Most major trials focused on acute changes, with follow-up durations typically extending only to a few weeks after the end of therapy.


Evidence for Use in Cutaneous Fungal Infections

Research has also examined Fenticonazole in studies of superficial skin conditions, including certain forms of tinea and cutaneous candidiasis. The evidence base for these indications comes from comparative clinical trials and parallel-group studies. In these studies, researchers monitored the mycological status of the skin (checking for fungal presence) and assessed overall clinical response, tracking changes in signs like redness, scaling, and inflammation. Data show patterns related to the measured mycological status and changes in visible skin symptoms over the study period.


What Remains Uncertain in Fenticonazole Research

Research contributes to the broader evidence landscape, but evidence highlights what is known and what is still uncertain. Long-term effects are not fully established, as the follow-up durations in the major clinical trials were limited. Evidence quality varies across studies, with some older trials being open-label or having modest sample sizes. Subgroup findings are uncertain or limited for specific patient groups, such as those with recurrent infections, certain comorbidities, or non-adult populations. Comparative evidence is lacking in some areas, and the results reflect the specific conditions under which the studies were conducted, meaning research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen

Frequently Asked Questions (FAQ)

Common questions about Fenticonazole (FAQ)


Q: What is the difference between fenticonazole ovules and the vaginal cream?

The ovules and cream represent different dosage forms associated with specific strengths and application methods. The ovules contain fatty excipients, which are officially documented to damage the structural integrity of latex barrier contraceptives. The different formulations are aligned with specific, officially defined treatment regimens.


Q: Can fenticonazole cause systemic side effects like headaches or stomach issues?

According to official product information, Fenticonazole exhibits very low absorption into the bloodstream following local application. For this reason, the safety profile primarily features localized application site reactions, such as burning or itching. Systemic side effects like headache or stomach issues are not reported among the common or very rare adverse reactions in the regulatory labeling.


Q: What are the warning signs of a severe allergic reaction to fenticonazole?

The official documentation states there is a potential for severe hypersensitivity or allergic reactions. Regulatory documents indicate that treatment should be stopped immediately if signs of sensitization occur, such as a rash or severe irritation that extends beyond the treated area. Such reactions are considered significant and require evaluation.


Q: What is the recommendation for sexual activity during treatment with fenticonazole?

Due to the documented risk of product excipients damaging the latex in barrier contraceptives (condoms and diaphragms), these methods may be rendered ineffective. Official guidance on use conditions states that alternative, reliable methods of contraception or abstinence from sexual intercourse are necessary during treatment and for a few days following treatment completion.


Q: How does the way fenticonazole works compare to medicines like clotrimazole?

Fenticonazole is classified as an Imidazole Antifungal agent, placing it in the same chemical family as clotrimazole. Research indicates Fenticonazole features a broad-spectrum action, extending its activity to include certain Gram-positive bacteria and the protozoan Trichomonas vaginalis, in addition to various fungi.


Q: What should I do if my symptoms do not improve after finishing the full course of treatment?

Official documents state that if the short-course regimen proves insufficient, the treatment may be repeated after three days. The labeling specifies that individuals with persistent symptoms or a history of recurrent infections, defined as more than two in six months, are required to receive a prior physician consultation.


Q: Is it typical for some of the product to leak out of the vagina after using the ovule?

The ovules utilize fatty excipients that are designed to dissolve once inserted. Instructions for use recommend inserting the ovule deeply at bedtime to promote maximum contact time. These instructions guide usage to minimize potential product leakage while the body is resting.


Q: Does fenticonazole interact with any common over-the-counter pain relievers?

Regulatory documents state that due to the drug’s very low systemic absorption following local use, the risk of clinically significant interactions with orally taken medicines is generally described as minimal. This principle applies to most common over-the-counter pain relievers.


Q: What is the meaning of 'imidazole derivative' as it relates to fenticonazole?

An imidazole derivative is a chemical classification that defines the medicine’s chemical family, which is the azole class of antifungals. This classification indicates that the drug works by disrupting the structure of fungal cell membranes through the inhibition of ergosterol synthesis.


Q: Can fenticonazole be used for infections caused by bacteria instead of fungi?

The drug's mechanism of action is classified as broad-spectrum, showing activity against certain Gram-positive bacteria and the protozoan Trichomonas vaginalis. However, the primary clinical indication specified in official documents for Fenticonazole is for the treatment of mycotic infections (fungal infections).


Q: How is fenticonazole different from oral antifungal treatments like fluconazole?

Fenticonazole is designed for localized, topical use, meaning the drug is applied directly to the site of infection. This results in very low systemic absorption into the rest of the body. Oral antifungal treatments, by contrast, are absorbed throughout the body to treat systemic or non-localized infections.


Q: Is it possible for my symptoms to temporarily worsen right after starting fenticonazole?

The safety profile for Fenticonazole is characterized by localized, transient reactions at the application site, such as a burning sensation, itching, or redness. These symptoms are documented in clinical reports as generally rare and rapidly resolving, and are considered local adverse reactions.


Q: How quickly should I expect to feel better after using fenticonazole?

Research examining the drug’s activity describes patterns of a rapid onset of action, with clinical efficacy generally observed within days of beginning treatment. Treatment regimens define the full prescribed course as necessary for proper use, regardless of how quickly symptoms may appear to improve.

How should Fenticonazole be stored and disposed of?

How to Store and Dispose of Fenticonazole

Fenticonazole must be stored and disposed of according to official regulatory requirements to maintain its stability and prevent environmental harm.


Mandatory Storage Conditions

Condition Requirement
Temperature Store below 30 C
Protection Keep in the original package and protect from light and moisture
Child Safety Store out of the sight and reach of children
Shelf-Life Do not use after the expiry date

Official Disposal Rules

Unused or expired Fenticonazole must be disposed of in accordance with local requirements. Medicines should not be disposed of via wastewater or household waste. It is officially recommended to ask a pharmacist how to discard any medicines no longer needed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Fenticonazole found in:

A-Z Index: